A Four-Year Randomized Controlled Trial of Hormone Replacement and Bisphosphonate, Alone or in Combination, in Women with Postmenopausal Osteoporosis
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 104 (3) , 219-226
- https://doi.org/10.1016/s0002-9343(98)00029-1
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized studyThe American Journal of Medicine, 1995
- Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosisThe American Journal of Medicine, 1993
- CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSSThe Lancet, 1988
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Consensus development conference: prophylaxis and treatment of osteoporosis.BMJ, 1987
- AN EPIDEMIOLOGIC STUDY OF HIP FRACTURE IN POSTMENOPAUSAL WOMENAmerican Journal of Epidemiology, 1982
- The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.American Journal of Public Health, 1981
- Prospective trial of oestrogen and calcium in postmenopausal women.BMJ, 1977
- Non-linear bone loss in oophorectomized womenThe British Journal of Radiology, 1977
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976